LifeVantage Co. (NASDAQ:LFVN – Get Free Report)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.42 and traded as low as $6.03. LifeVantage shares last traded at $6.05, with a volume of 42,786 shares.
LifeVantage Price Performance
The company has a 50 day moving average price of $6.59 and a 200 day moving average price of $6.42. The firm has a market cap of $79.40 million, a PE ratio of 26.83 and a beta of 0.78.
LifeVantage (NASDAQ:LFVN – Get Free Report) last released its quarterly earnings results on Tuesday, January 30th. The company reported $0.10 EPS for the quarter. The business had revenue of $51.62 million during the quarter. LifeVantage had a return on equity of 19.96% and a net margin of 1.40%.
LifeVantage Announces Dividend
Institutional Inflows and Outflows
A hedge fund recently raised its stake in LifeVantage stock. Ritholtz Wealth Management grew its position in LifeVantage Co. (NASDAQ:LFVN – Free Report) by 23.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,027 shares of the company’s stock after buying an additional 4,756 shares during the quarter. Ritholtz Wealth Management owned 0.20% of LifeVantage worth $150,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 35.32% of the company’s stock.
About LifeVantage
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.
Featured Stories
- Five stocks we like better than LifeVantage
- What is the Nikkei 225 index?
- High-Yield Texas Instruments Could Hit New Highs Soon
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.